Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation

COLUMBIA, S.C. (April 30, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL). It is part of a 12-product, six-month rollout from Ritedose for hospital pharmacies across the coun

Labetalol HCI Injection Vial, USP 20 mg/4 mL (5 mg/mL

00409-3375-04 Pfizer Hospital US

Hospira 00409121501 - McKesson Medical-Surgical

Hospira 00409490334 - McKesson Medical-Surgical

News – The Ritedose Corporation

The Ritedose Corporation

News – Page 2 – The Ritedose Corporation

Pfizer 00409177805 - McKesson Medical-Surgical

Fresenius USA 63323048257 - McKesson Medical-Surgical